| Literature DB >> 32423387 |
Anas AlYousef1, Ali AlSahow2, Bassam AlHelal3, Ahmed Alqallaf4, Emad Abdallah3, Mohammed Abdellatif5, Hani Nawar2, Riham Elmahalawy4.
Abstract
BACKGROUND: Glomerulonephritides (GN) are relatively rare kidney diseases with substantial morbidity and mortality. They are often difficult to treat, sometimes with no cure, and can lead to chronic kidney disease (CKD) and end stage kidney disease (ESKD). Kidney biopsy is the diagnostic procedure of choice with variable indications from center to center. It helps in identifying the exact specific diagnosis, assessing the level of disease activity and severity, and hence aids in proper therapy and helps predicting prognosis. There is a global change of pattern of glomerular disease over the last five decades.Entities:
Keywords: Diabetic Kidney Disease; Glomerulonephritis; IgA Nephropathy; Kidney Biopsy Nephrotic Syndrome
Year: 2020 PMID: 32423387 PMCID: PMC7236312 DOI: 10.1186/s12882-020-01836-3
Source DB: PubMed Journal: BMC Nephrol ISSN: 1471-2369 Impact factor: 2.388
Indications of Kidney Biopsy (Clinical Presentation)
| Clinical Syndrome | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | Total N | Percent |
|---|---|---|---|---|---|---|---|---|
| Sub-nephrotic Proteinuria plus AKI | 11 | 22 | 52 | 32 | 23 | 39 | 179 | 32.8 % |
| Nephrotic Syndrome | 8 | 20 | 18 | 12 | 29 | 30 | 117 | 21.5 % |
| Nephrotic Syndrome plus AKI | 8 | 11 | 12 | 19 | 22 | 17 | 89 | 16.3 % |
| Unexplained Renal Impairment | 10 | 7 | 11 | 20 | 9 | 14 | 71 | 13 % |
| Sub-nephrotic Proteinuria | 7 | 8 | 23 | 3 | 10 | 14 | 65 | 11.9 % |
| Isolated Hematuria | 2 | 2 | 6 | 5 | 1 | 8 | 24 | 4.4 % |
Fig. 1Indications of Kidney Biopsy
Primary Glomerulonephritis
| Glomerulopathy Type | Number of cases | Percent |
|---|---|---|
| IgAN | 85 | 23.9 % |
| Membranous Nephropathy | 79 | 22.2 % |
| FSGS | 78 | 21.9 % |
| MCD | 50 | 14.0 % |
| MPGN | 11 | 3.1 % |
| Crescentic GN | 21 | 5.9 % |
| Extensive Glomerulosclerosis | 24 | 6.7 % |
| Other primary GN | 8 | 2.2 % |
| Total | 356 | 100.0 |
Secondary Glomerulonephritis
| Glomerulopathy Type | Number of cases | Percent |
|---|---|---|
| Lupus Nephritis | 56 | 41.8 |
| Diabetic Kidney Disease | 27 | 20.2 |
| ANCA Vasculitis | 13 | 9.7 |
| TMA | 12 | 8.9 |
| Amyloidosis | 6 | 4.5 |
| Post infectious GN | 6 | 4.5 |
| Hypertensive Nephropathy | 9 | 6.7 |
| Light chain cast nephropathy | 5 | 3.7 |
| Total | 134 | 100.0 |
Tubulointerstitial Disease
| Tubulointerstitial | Number of cases | Percent |
|---|---|---|
| Acute interstitial nephritis | 30 | 66.7 |
| Chronic interstitial nephritis | 10 | 22.2 |
| Other tubulointerstitial disease | 5 | 11.1 |
| Total | 45 | 100.0 |
Clinical Presentation and Correlative Histopathology
| Diagnosis | Sub-nephrotic Proteinuria plus AKI | Nephrotic syndrome | Nephrotic Syndrome plus AKI | Sub-nephrotic Proteinuria | Isolated Hematuria | Unexplained renal impairment |
|---|---|---|---|---|---|---|
| Lupus Nephritis | 16 | 14 | 7 | 13 | 2 | 4 |
| FSGS | 37 | 15 | 11 | 11 | 0 | 4 |
| MN | 6 | 36 | 24 | 11 | 1 | 1 |
| MCD | 2 | 34 | 6 | 8 | 0 | 0 |
| IgAN | 42 | 8 | 10 | 9 | 11 | 5 |
| MPGN | 3 | 1 | 4 | 1 | 1 | 1 |
| ANCA Vasculitis | 1 | 0 | 0 | 3 | 1 | 8 |
| Crescentic GN | 11 | 2 | 7 | 0 | 1 | 0 |
| DKD1 | 16 | 1 | 7 | 2 | 0 | 6 |
| TMA2 | 7 | 0 | 0 | 1 | 2 | 2 |
| AIN | 11 | 0 | 0 | 1 | 0 | 18 |
| CIN3 | 5 | 0 | 1 | 1 | 0 | 3 |
| Extensive glomerulosclerosis | 11 | 1 | 2 | 0 | 0 | 5 |
| HTN Nephropathy | 3 | 0 | 0 | 0 | 1 | 5 |
| Alport Syndrome | 1 | 1 | 0 | 0 | 0 | 0 |
| Inadequate Biopsy | 0 | 0 | 0 | 1 | 0 | 5 |
| C3 Glomerulopathy | 0 | 0 | 0 | 0 | 0 | 1 |
| IgG4 | 0 | 0 | 0 | 0 | 0 | 1 |
| Thin Basement Membrane | 0 | 0 | 0 | 1 | 1 | 0 |
| Granulomatous Nephritis | 0 | 0 | 0 | 0 | 0 | 1 |
| Renal amyloidosis | 1 | 2 | 3 | 0 | 0 | 0 |
| Post infectious GN | 4 | 0 | 0 | 0 | 2 | 0 |
| Pigment nephropathy | 1 | 0 | 0 | 0 | 0 | 0 |
| Light chain cast nephropathy | 1 | 0 | 4 | 0 | 0 | 0 |
| Normal kidney biopsy | 0 | 3 | 0 | 0 | 1 | 0 |
| Lymphomatous Infiltrate (CLL) | 0 | 0 | 1 | 0 | 0 | 0 |
| Tubular adenoma | 0 | 0 | 1 | 0 | 0 | 0 |
| Fibrillary GN | 0 | 0 | 1 | 0 | 0 | 0 |
| Total | 179 | 117 | 89 | 65 | 24 | 71 |
(1) DKD Diabetic Kidney Disease. (2) TMA Thrombotic Microangiopathy. (3) CIN Chronic Interstitial Nephritis.
Histopathological Patterns in Diabetic Patients
| Diagnosis | Number of cases | Percent |
|---|---|---|
| Diabetic Kidney Disease | 27 | 22.5 % |
| FSGS | 23 | 19.2 % |
| IgA Nephropathy | 13 | 10.8 % |
| Extensive glomerulosclerosis | 13 | 10.8 % |
| Lupus nephritis | 9 | 7.5 % |
| Membranous Nephropathy | 7 | 5.8 % |
| MCD | 3 | 2.5 % |
| MPGN | 2 | 1.7 % |
| Focal necrotizing GN | 4 | 3.3 % |
| Crescentic GN | 3 | 2.5 % |
| AIN | 6 | 5 % |
| HTN Nephropathy | 3 | 2.5 % |
| Thrombotic Microangiopathy | 1 | 0.8 % |
| C3 Glomerulopathy | 1 | 0.8 % |
| Chronic Interstitial Nephritis | 1 | 0.8 % |
| Renal Amyloidosis | 1 | 0.8 % |
| Post infectious glomerulonephritis | 1 | 0.8 % |
| Inadequate Biopsy | 2 | 1.7 % |
| Total | 120 | 100 % |
Clinical Presentations and Histopathological Results in patients less than 18 years
| Sub-nephrotic Proteinuria | 11 | 35.5 % |
| Nephrotic Syndrome | 9 | 29 % |
| Sub-nephrotic Proteinuria plus AKI | 7 | 22.6 |
| Nephrotic Syndrome plus AKI | 2 | 6.5 % |
| Unexplained deterioration in kidney function | 2 | 6.5 % |
| Total Number | 31 | 100% |
| MCD | 11 | 35.5 % |
| MPGN | 3 | 9.7 % |
| IgA Nephropathy | 3 | 9.7 % |
| Lupus nephritis | 3 | 9.7 % |
| Membranous Nephropathy | 2 | 6.5 % |
| FSGS | 2 | 6.5 % |
| AIN | 2 | 6.5 % |
| Crescentic GN | 1 | 3.2 % |
| Post infectious GN | 1 | 3.2 % |
| Chronic Interstitial Nephritis | 1 | 3.2 % |
| Focal necrotizing GN | 1 | 3.2 % |
| Alport Syndrome | 1 | 3.2 % |
| Total Number | 31 | 100% |
Fig. 2.Top Histopathological Results
Fig. 3.Histopathological Pattern in Diabetic Patients